Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Watch for: MOTS-C: mild energy changes weeks 12, more noticeable improvement by week 34 5-Amino-1MQ: subtle metabolic shift, most noticeable when combined with consistent Zone 2 cardio NAD+: gradual energy improvement, not stimulant-like Timing: Reta: once weekly subQ MOTS-C: 500mcg/day subQ, morning fasted or pre-workout NAD+ (NMN/NR): morning with food 5-Amino-1MQ: morning, fasted or with NAD+ supplement What to Realistically Expect 5-Amino-1MQ is not a dramatic compound
The clearest guidance comes from injection science more broadly
At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC of 1.2 0.1 M under standard assay conditions (50 M SAM, 100 M nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity
Thorburn, E
In February 2022, Kyle Mullen, a 24-year-old SEAL candidate from New Jersey, died shortly after completing Hell Week
